Method for neural stem cell differentiation using 5HT-1A...

Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S029000, C435S352000, C435S363000

Reexamination Certificate

active

07132287

ABSTRACT:
The present invention relates to a method for differentiating a neural stem cell into a neuronal cell such as a neuroblast or a neuron in vitro or in vivo. Particularly, the invention provides for a method for neural stem cell differentiation by contacting the neural stem cell with a 5HT1A ligand or agonist.

REFERENCES:
patent: 5753506 (1998-05-01), Johe et al.
patent: 5766948 (1998-06-01), Gage et al.
patent: 5851832 (1998-12-01), Weiss et al.
patent: 6103530 (2000-08-01), Carpenter et al.
patent: 6149902 (2000-11-01), Artavanis-Tsakonas et al.
patent: 97/08159 (1997-03-01), None
patent: 00/16777 (2000-03-01), None
patent: 01/34586 (2001-05-01), None
Mattson MP. Stem cells as therapeutics for neurodegenerative disorders? Exp. Rev. Neurotherap. (2001), 1(2), 267-273.
Kordower et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med. Apr. 27, 1995;332(17):1118-24.
Freeman et al. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol. Sep. 1995;38(3):379-88.
Widner et al. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) N Engl J Med. Nov. 26, 1992;327(22):1556-63.
Barker et al. Neural transplantation therapies for Parkinson's and Huntington's diseases. Drug Discov Today. Jun. 1, 2001;6(11):575-582.
Lindvall et al. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat Med. Jul. 2004;10 Suppl:S42-50.
Isacson O. The production and use of cells as therapeutic agents in neurodegenerative diseases. Lancet Neurol. Jul. 2003;2(7):417-24.
Weissman IL. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science. Feb. 25, 2000;287(5457):1442-6.
Protais et al. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone. Eur J Pharmacol. Jul. 10, 1998;352(2-3):179-87.
Zhou et al. Mechanisms governing the differentiation of a serotonergic phenotype in culture. Brain Res. Sep. 15, 2000;877(1):37-46.
Vicario-Abejon et al. Hippocampal stem cells differentiate into excitatory and inhibitory neurons. Eur J Neurosci. Feb. 2000;12(2):677-88.
Buznikov et al., “Serotonin and Serotonin-Like Substances as Regulators of Early Embryogenesis and Morphogenesis,”Cell Tissue Res., Aug. 2001, vol. 305, No. 2, pp. 177-186.
Chumasov et al., “Effect of Serotonin on Growth and Differentiation of Hippocampal Cells in Culture,”Neurosci. Behav. Physiol., Mar. 1980, vol. 10, No. 2, pp. 125-131.
Chubakov et al., “Effect of Serotonin on the Development of a Rat Cerebral Cortex Tissue Culture,”Neurosci. Behav. Physiol., Nov. 1986, vol. 16, No. 6, pp. 490-497.
Chubakov et al., “Effect of Serotonin on the Morpho-Functional Development of a Rat Cerebral Neocortex in Tissue Culture,”Brain Res., Mar. 1986, vol. 369, pp. 285-297.
Abe, “Therapeutic Potential of Neurotrophic Factors and Neural Stem Cells Against Ischemic Brain Injury,”Cereb. Blood Flow Metab., Oct. 2000, vol. 20, No. 10, pp. 1393-1408.
Ourednik et al., “Neural Stem Cells—A Versatile Tool for Cell Replacement and Gene Therapy in the Central Nervous System,”Clin. Genet., Oct. 1999, vol. 56, No. 4, pp. 267-278.
Lieske et al., “Effects of Serotonin on Neurite Outgrowth from Thalamic NeuronsIn Vitro,” Neuroscience, Mar. 1999, vol. 90, No. 3, pp. 967-974.
Semkova et al., “Neuroprotective Effect of 5-HT1AReceptor Agonist, Bay X 3702, Demonstrated In Virto and In Vivo,”Eur. J. Pharmacol, Oct. 1998, vol. 359, pp. 251-260.
Shetty and Turner, J Neurobiol. 1998;35:395-425.
Caldwell et al., Nat Biotechnol. 2001;19:475 9.
Mahlberg, et al., J Neurosci. 2000;20:9104-10.
Yocca, J Clin Psychipharmacology 1990;10(suppl., 3):6S-12S.
Durig et al., Dev Neurosci 2000; 11:833-837.
Lavdas et al., J Neurosci 1997; 17:7872-7880.
Jacobs et al., Mol Psychiatry 2000; 4:262-69.
Schuldiner et al., Brain Res 2001; 913:201-205.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for neural stem cell differentiation using 5HT-1A... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for neural stem cell differentiation using 5HT-1A..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for neural stem cell differentiation using 5HT-1A... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3679950

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.